Motor Progression in Early-Stage Parkinson's Disease: A Clinical Prediction Model and the Role of Cerebrospinal Fluid Biomarkers
Background: The substantial heterogeneity of clinical symptoms and lack of reliable progression markers in Parkinson's disease (PD) present a major challenge in predicting accurate progression and prognoses. Increasing evidence indicates that each component of the neurovascular unit (NVU) and b...
Main Authors: | Ling-Yan Ma, Yu Tian, Chang-Rong Pan, Zhong-Lue Chen, Yun Ling, Kang Ren, Jing-Song Li, Tao Feng |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Aging Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fnagi.2020.627199/full |
Similar Items
-
Serial I-123-FP-CIT SPECT Image Findings of Parkinson's Disease Patients With Levodopa-Induced Dyskinesia
by: Eun Hye Jeong, et al.
Published: (2018-12-01) -
The Length of SNCA Rep1 Microsatellite May Influence Cognitive Evolution in Parkinson’s Disease
by: Lucia Corrado, et al.
Published: (2018-03-01) -
Biomarkers of Parkinson's disease: recent insights, current challenges, and future prospects
by: Picillo M, et al.
Published: (2016-02-01) -
Evaluation of RNA Blood Biomarkers in the Parkinson’s Disease Biomarkers Program
by: Jose A. Santiago, et al.
Published: (2018-05-01) -
Progressive Gait Deficits in Parkinson’s Disease: A Wearable-Based Biannual 5-Year Prospective Study
by: Markus A. Hobert, et al.
Published: (2019-02-01)